Geode Capital Management, LLC Omega Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 230,833 shares of OMGA stock, worth $173,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares

230,833

Previous 236,833 2.53%

Holding current value

$173,124

Previous $490,000 42.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.22 - $2.25 $7,320 - $13,500	-6,000 Reduced 2.53%	230,833 $281,000
Q2 2024 Aug 09, 2024	SELL	$1.86 - $3.2 $490,428 - $843,747	-263,671 Reduced 52.68%	236,833 $490,000
Q1 2024 May 13, 2024	BUY	$2.73 - $5.32 $62,424 - $121,647	22,866 Added 4.79%	500,504 $1.83 Million
Q4 2023 Feb 13, 2024	BUY	$1.35 - $3.21 $25,725 - $61,169	19,056 Added 4.16%	477,638 $1.44 Million
Q3 2023 Nov 13, 2023	BUY	$2.15 - $5.68 $33,669 - $88,948	15,660 Added 3.54%	458,582 $985,000
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $1.46 Million - $2.52 Million	261,379 Added 143.98%	442,922 $2.48 Million
Q4 2022 Feb 13, 2023	SELL	$4.22 - $7.05 $1,527 - $2,552	-362 Reduced 0.2%	181,543 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$3.63 - $6.65 $356,026 - $652,225	98,079 Added 117.0%	181,905 $985,000
Q2 2022 Aug 12, 2022	SELL	$2.01 - $7.19 $380,030 - $1.36 Million	-189,070 Reduced 69.28%	83,826 $318,000
Q1 2022 May 13, 2022	BUY	$6.24 - $14.04 $908,175 - $2.04 Million	145,541 Added 114.28%	272,896 $1.7 Million
Q4 2021 Feb 11, 2022	BUY	$11.33 - $29.38 $628,350 - $1.63 Million	55,459 Added 77.14%	127,355 $1.44 Million
Q3 2021 Nov 12, 2021	BUY	$16.0 - $22.51 $1.15 Million - $1.62 Million	71,896 New	71,896 $1.36 Million

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.4M

Call Options Held

25.8K

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $35.9M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Omega Therapeutics, Inc. Transaction History